# | Aladdin ID | Assay Type | Description | Organism | Compounds | Reference | BAO Format | Source | |
---|---|---|---|---|---|---|---|---|---|
1. | ALA4724191 | A | Metabolic stability in CD-1 mouse liver microsomes assessed as parent compound remaining at 100 uM measured after 60 mins by LC-MS/MS analysis | Mus musculus | 5 | ALA4715878 | microsome format | Scientific Literature | |
2. | ALA4724192 | A | Metabolic stability in CD-1 mouse liver microsomes assessed as parent compound remaining at 100 uM measured after 60 mins in presence of NADPH by LC-MS/MS analysis | Mus musculus | 5 | ALA4715878 | microsome format | Scientific Literature | |
3. | ALA4724193 | A | Intrinsic clearance in CD-1 mouse liver microsomes at 100 uM measured after 60 mins in presence of NADPH by LC-MS/MS analysis | Mus musculus | 5 | ALA4715878 | microsome format | Scientific Literature | |
4. | ALA4724194 | A | Intrinsic clearance in CD-1 mouse microsomes at 100 uM measured after 60 mins in presence of NADPH by LC-MS/MS analysis | Mus musculus | 5 | ALA4715878 | microsome format | Scientific Literature | |
5. | ALA4724195 | A | Metabolic stability in CD-1 mouse liver microsomes assessed as half-life at 100 uM measured after 60 mins in presence of NADPH by LC-MS/MS analysis | Mus musculus | 5 | ALA4715878 | microsome format | Scientific Literature | |
6. | ALA4724196 | F | Antitumor activity against human BT474 cells xenografted in athymic nude mouse assessed as reduction in metastasis of cells at 50 mg/kg, po administered via oral gavage for 5 times per week for 55 days measured post-last dose | Homo sapiens | 2 | ALA4715878 | organism-based format | Scientific Literature | |
7. | ALA4724197 | F | Antitumor activity against human BT474 cells xenografted in athymic nude mouse assessed as suppression of tumor growth by measuring decrease in number of Ki67 positive cells at 50 mg/kg, po administered via oral gavage for 5 times per week for 55 days measured post-last dose by Ki67-staining based immunohistochemistry | Homo sapiens | 2 | ALA4715878 | organism-based format | Scientific Literature | |
8. | ALA4724198 | F | Antitumor activity against human BT474 cells xenografted in athymic nude mouse assessed as inflammation in tumors at 50 mg/kg, po administered via oral gavage for 5 times per week for 55 days measured post-last dose by H and E staining based immunohistochemical analysis | Homo sapiens | 2 | ALA4715878 | organism-based format | Scientific Literature | |
9. | ALA4724199 | F | Antitumor activity against human BT474 cells xenografted in athymic nude mouse assessed as appearance of tumor fibrosis at 50 mg/kg, po administered via oral gavage for 5 times in a week for 55 days measured post-last dose by H and E staining based immunohistochemical analysis | Homo sapiens | 2 | ALA4715878 | organism-based format | Scientific Literature | |
10. | ALA4724200 | F | Antitumor activity against human BT474 cells xenografted in athymic nude mouse assessed as tumor necrosis at 50 mg/kg, po administered via oral gavage for 5 times in a week for 55 days measured post-last dose by H and E staining based immunohistochemical analysis | Homo sapiens | 2 | ALA4715878 | organism-based format | Scientific Literature | |
11. | ALA4724201 | F | Antitumor activity against human BT474 cells xenografted in athymic nude mouse assessed as tumor weight at 50 mg/kg, po administered via oral gavage for 5 times in a week for 55 days measured post last dose (Rvb = 2.046 g) | Homo sapiens | 2 | ALA4715878 | organism-based format | Scientific Literature | |
12. | ALA4724202 | F | Antitumor activity against human BT474 cells xenografted in athymic nude mouse assessed as tumor growth inhibition at 50 mg/kg, po administered via oral gavage for 5 times in a week for 55 days measured post last dose | Homo sapiens | 2 | ALA4715878 | organism-based format | Scientific Literature | |
13. | ALA4724211 | B | Inhibition of HER2 in human BT474 cells assessed as reduction in Erk1/2 phosphorylation at 0.5 IC50 incubated for 24 to 48 hrs by western blot analysis | Homo sapiens | 1 | ALA4715878 | cell-based format | Scientific Literature | |
14. | ALA4724212 | B | Inhibition of HER2 in human BT474 cells assessed as reduction in Erk1/2 phosphorylation at 0.1 IC50 incubated for 24 to 48 hrs by western blot analysis | Homo sapiens | 1 | ALA4715878 | cell-based format | Scientific Literature | |
15. | ALA4724213 | B | Inhibition of HER2 in human BT474 cells assessed as reduction in Akt phosphorylation at 0.5 IC50 incubated for 24 to 48 hrs by western blot analysis | Homo sapiens | 1 | ALA4715878 | cell-based format | Scientific Literature | |
16. | ALA4724214 | B | Inhibition of HER2 in human BT474 cells assessed as reduction in Akt phosphorylation at 0.1 IC50 incubated for 24 to 48 hrs by western blot analysis | Homo sapiens | 1 | ALA4715878 | cell-based format | Scientific Literature | |
17. | ALA4724215 | B | Inhibition of HER2 in human BT474 cells assessed as reduction in Akt phosphorylation at 0.1 IC50 after 24 to 48 hrs by Western blot analysis | Homo sapiens | 1 | ALA4715878 | cell-based format | Scientific Literature | |
18. | ALA4724216 | B | Inhibition of HER2 in human BT474 cells assessed as reduction in Akt phosphorylation at 0.5 IC50 after 24 to 48 hrs by Western blot analysis | Homo sapiens | 1 | ALA4715878 | cell-based format | Scientific Literature | |
19. | ALA4724217 | F | Down regulation of HER2 expression in human BT474 cells at 0.1 IC50 after 24 to 48 hrs by Western blot analysis | Homo sapiens | 1 | ALA4715878 | cell-based format | Scientific Literature | |
20. | ALA4724218 | F | Down regulation of HER2 expression in human BT474 cells at 0.5 IC50 after 24 to 48 hrs by Western blot analysis | Homo sapiens | 1 | ALA4715878 | cell-based format | Scientific Literature |